Exploring 25I-NBOMe. To explore a different substance…

25I-NB2OMe; Cimbi-5-2
Names:
25I-NB2OMe · 25I-NBOMe · INBMeO · NBOMe-2CI · Cimbi-5-2 · Cimbi-5 · N-(2-Methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine · 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
IUPAC names:
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethan-1-amine
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine
ID: 5380 · Formula: C18H22INO3 · Molecular weight: 427.277
InChI: InChI=1S/C18H22INO3/c1-21-16-7-5-4-6-14(16)12-20-9-8-13-10-18(23-3)15(19)11-17(13)22-2/h4-7,10-11,20H,8-9,12H2,1-3H3

Blaazer, AR; Smid, P; Kruse, CG. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors. ChemMedChem, 15 Sep 2008, 3 (9), 1299–1309. 461 kB. http://dx.doi.org/10.1002/cmdc.200800133

Heim, R; Pertz, HH; Elz, MZS. Stereoselective synthesis, absolute configuration and 5-HT2A-receptor agonism of chiral 2-methoxybenzylamines. Arch. Pharm. Pharm. Med. Chem., Oct 2002, 335 (Suppl. 1), 82. 573 kB. Poster abstract

Anon. Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe), European Monitoring Centre for Drugs and Drug Addiction, Apr 2014.

Casale, JF; Hays, PA. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues—Part I. Microgram J., 1 Jan 2012, 9 (2), 84–109. 4601 kB.

Parrish, JC. Toward a molecular understanding of hallucinogen action. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2006. 5475 kB.

Braden, MR. Towards a biophysical understanding of hallucinogen action. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2007. 8442 kB.

Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain. Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7921 kB.

Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5904 kB.

Heim, R. Synthesis and pharmacology of potent 5-HT2A receptor agonists with N-2-methoxybenzyl partial structure. SC. D. Thesis, Freie Universität, Berlin, 1 Jan 2004. In German.

Heim, R; Elz, S. Novel extremely potent partial 5-HT2A-receptor agonists: Successful application of a new structure-activity concept. Arch. Pharm. Pharm. Med. Chem., Mar 2000, 333 (Suppl. 1), 18. 566 kB. Poster abstract

Anon. Personal communication of unpublished research. 1 Dec 2011.

Brandt, SD; Elliott, SP; Kavanagh, PV; Dempster, NM; Meyer, MR; Maurer, HH; Nichols, DE. Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines. Rapid Commun. Mass Spectrom., 2 Mar 2015, 29 (7), 573–584. 2154 kB. http://dx.doi.org/10.1002/rcm.7134

Ettrup, A; Hansen, M; Santini, MA; Paine, J; Gillings, N; Palner, M; Lehel, S; Herth, MM; Madsen, J; Kristensen, JL; Begtrup, M; Knudsen, GM. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers. Eur. J. Nucl. Med. Mol. Imaging, 1 Apr 2011, 38 (4), 681–693. 752 kB. http://dx.doi.org/10.1007/s00259-010-1686-8

Silva, ME; Heim, R; Strasser, A; Elz, S; Dove, S. Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor. J. Comput. Aided Mol. Des., 1 Jan 2011, 25 (1), 51–66. 834 kB. http://dx.doi.org/10.1007/s10822-010-9400-2

Leth-Petersen, S; Bundgaard, C; Hansen, M; Carnerup, MA; Kehler, J; Kristensen, JL. Correlating the metabolic stability of psychedelic 5-HT2A agonists with anecdotal reports of human oral bioavailability. Neurochem. Res., 625 kB. http://dx.doi.org/10.1007/s11064-014-1253-y

Nichols, DE; Frescas, SP; Chemel, BR; Rehder, KS; Zhong, D; Lewin, AH. High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand. Bioorg. Med. Chem., 1 Jan 2008, 16 (10), 6116–6123. 251 kB. http://dx.doi.org/10.1016/j.bmc.2008.04.050

Nichols, DE; Sassano, MF; Halberstadt, AL; Klein, LM; Brandt, SD; Elliott, SP; Fiedler, WJ. N-Benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with a series of phenethylamine analogues. ACS Chem. Neurosci., 29 Dec 2014. 406 kB. http://dx.doi.org/10.1021/cn500292d

Braden, MR; Parrish, JC; Naylor, JC; Nichols, DE. Molecular interaction of serotonin 5-HT2A receptor residues Phe339^(6.51) and Phe340^(6.52) with superpotent N-benzyl phenethylamine agonists. Mol. Pharmacol., 1 Jan 2006, 70 (6), 1956–1964. 361 kB. http://dx.doi.org/10.1124/mol.106.028720

Chapman, SJ; Avanes, AA. PeakAL: Protons I Have Known and Loved — Fifty Shades of Grey-Market Spectra. BLOTTER, 1 Aug 2015. 2608 kB. http://dx.doi.org/10.16889/isomerdesign-1 Open access DOI

Chapman, SJ; Avanes, AA. PeakAL: Protons I Have Known and Loved — Fifty Shades of Grey-Market Spectra. Supplementary Data. BLOTTER, 1 Aug 2015. 11879 kB. http://dx.doi.org/10.16889/isomerdesign-1-supp Open access DOI

Ettrup, A; Palner, M; Gillings, N; Santini, MA; Hansen, M; Kornum, BR; Rasmussen, LK; Nagren, K; Madsen, J; Begtrup, M; Knudsen, GM. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET. J. Nucl. Med., 1 Nov 2010, 51 (11), 1763–1770. 548 kB. http://dx.doi.org/10.2967/jnumed.109.074021

2C-I
PiHKAL#33 2C-I; SI#23 2C-I
25I-NBOH
25I-NBOH; Cimbi-27
25I-NNap
25I-NNap; 4-Iodo-2,5-dimethoxy-N-(naphthalen-2-ylmethyl)phenethylamine
INBMDO · 25I-NBMD
INBMDO; Cimbi-29
25I-NMeFur
25I-NMeFur; N-(Furan-2-ylmethyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NMeThiop
25I-NMeThiop; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(thiophen-2-ylmethyl)ethan-1-amine
25I-NMePyr
25I-NMePyr; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(pyridin-2-ylmethyl)ethan-1-amine
25I-NBCN
25I-NBCN; N-(2-Cyanobenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NBAm
25I-NBAm; N-(2-Carbamoylbenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NMeInd
25I-NMeInd; N-(Indole-3-ylmethyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NNap2
25I-NNap2; 4-Iodo-2,5-dimethoxy-N-(naphthalen-1-ylmethyl)phenethylamine
25I-NBMeOH
25I-NBMeOH; N-[2-(Hydroxymethyl)benzyl]-4-iodo-2,5-dimethoxyphenethylamine
25I-NDHF
25I-NDHF; 4-Iodo-2,5-dimethoxy-N-(tetrahydrofuran-2-ylmethyl)phenethylamine
25I-N2Nap3OH
25I-N2Nap3OH; N-(3-Hydroxynaphthalen-2-yl)-4-iodo-2,5-dimethoxyphenethylamine
25I-N1Nap2OH
25I-N1Nap2OH; N-[(2-Hydroxynaphthalen-1-yl)methyl]-4-iodo-2,5-dimethoxyphenethylamine
25I-NBOH45MD
25I-NBOH45MD; N-(2-Hydroxy-4,5-methylenedioxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-N2Nap1OH
25I-N2Nap1OH; N-[(1-Hydroxynaphthalen-2-yl)methyl]-4-iodo-2,5-dimethoxyphenethylamine
25I-NB34MD
25I-NB34MD; 4-Iodo-2,5-dimethoxy-N-(3,4-methylenedioxybenzyl)phenethylamine
25I-NBpTFM
25I-NBpTFM; 4-Iodo-2,5-dimethoxy-N-[4-(trifluoromethyl)benzyl]phenethylamine
25I-NBTFM
25I-NBTFM; 4-Iodo-2,5-dimethoxy-N-[2-(trifluoromethyl)benzyl]phenethylamine
25I-NBF
25I-NBF; Cimbi-21
25I-NB4F · 25I-NBpF
25I-NB4F; N-(4-Fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
25I-NB
25I-NB; N-Benzyl-4-iodo-2,5-dimethoxyphenethylamine
N4MT3M-2C-I
N4MT3M-2C-I; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(4-methoxythiophen-3-yl)methyl]ethan-1-amine
N3MT2M-2C-I
N3MT2M-2C-I; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(3-methoxythiophen-2-yl)methyl]ethan-1-amine
25I-NEPOMe
25I-NEPOMe; N-[2-(4-Iodo-2,5-dimethoxyphenyl)ethyl]-1-(2-methoxyphenyl)ethan-1-amine
25I-NB3OMe
25I-NB3OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)ethan-1-amine
25I-NB4OMe
25I-NB4OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(4-methoxybenzyl)ethan-1-amine
25I-NB4B
25I-NB4B; N-(4-Bromobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
25I-NB3B
25I-NB3B; N-(3-Bromobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
25I-NBBr · 25I-NB2B
25I-NBBr; N-(2-Bromobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
DOI-NBOMe
DOI-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxyamphetamine
10477
N-[2-(2-Chlorophenyl)ethyl]acetamide
10568
3-[(4-Fluorophenyl)methyl]-N-methylpentan-3-amine
10566
1-(4-Fluorophenyl)-N,2-dimethylpropan-2-amine
10515
N-Ethyl-2-methyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine
10502
3-[(3-Fluorophenyl)methyl]-N-methylpentan-3-amine
10500
1-(3-Fluorophenyl)-N,2-dimethylpropan-2-amine
DMPEA-NBOMe · 25H-NBOMe
DMPEA-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxyphenethylamine
25B-NB2OMe · 25B-NBOMe
25B-NB2OMe; Cimbi-36
25D-NBOMe
25D-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxy-4-methylphenethylamine
25C-NB2OMe · 25C-NBOMe
25C-NB2OMe; Cimbi-82
25E-NBOMe
25E-NBOMe; 4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25T4-NBOMe
25T4-NBOMe; 4-Isopropylthio-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25EF-NBOMe
25EF-NBOMe; 4-(2-Fluoroethyl)-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25TFM-NBOMe
25TFM-NBOMe; Cimbi-138
25IP-NBOMe
25IP-NBOMe; 4-Isopropyl-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25CN-NBOMe
25CN-NBOMe; 2,5-Dimethoxy-4-{2-[(2-methoxybenzyl)amino]ethyl}benzonitrile
25F-NBOMe
25F-NBOMe; 2-(4-Fluoro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine
25N-NBOMe
25N-NBOMe; 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethan-1-amine
245-NBOMe
245-NBOMe; N-(2-Methoxybenzyl)-2-(2,4,5-trimethoxyphenyl)ethan-1-amine
25P-NBOMe
25P-NBOMe; 2-(2,5-Dimethoxy-4-propylphenyl)-N-(2-methoxybenzyl)ethan-1-amine
25T-NBOMe
25T-NBOMe; 2-[2,5-Dimethoxy-4-(methylsulfanyl)phenyl]-N-(2-methoxybenzyl)ethan-1-amine
25T2-NBOMe
25T2-NBOMe; 2-[4-(Ethylsulfanyl)-2,5-dimethoxyphenyl]-N-(2-methoxybenzyl)ethan-1-amine
25T7-NBOMe
25T7-NBOMe; 2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-(2-methoxybenzyl)ethan-1-amine
IBOX
IBOX; 8-Iodo-7-methoxy-2,3,4,5-tetrahydro-1-benzoxepin-4-amine
Propargylpemoline
Propargylpemoline
10846
2-(Dimethylamino)-5-methyl-5-phenyl-1,3-oxazol-4(5H)-one
738
2-(4-Iodo-2,5-dimethoxyphenyl)cyclopropanamine
25I-NBMeOH
25I-NBMeOH; N-[2-(Hydroxymethyl)benzyl]-4-iodo-2,5-dimethoxyphenethylamine
DOI-NBOH
DOI-NBOH; 2-({[1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-yl]amino}methyl)phenol
25I-NB3OMe
25I-NB3OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)ethan-1-amine
25I-NB4OMe
25I-NB4OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(4-methoxybenzyl)ethan-1-amine
2C-I
PiHKAL#33 2C-I; SI#23 2C-I
25I-NBOH
25I-NBOH; Cimbi-27
25I-NNap
25I-NNap; 4-Iodo-2,5-dimethoxy-N-(naphthalen-2-ylmethyl)phenethylamine
INBMDO · 25I-NBMD
INBMDO; Cimbi-29
25I-NMeFur
25I-NMeFur; N-(Furan-2-ylmethyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NMeThiop
25I-NMeThiop; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(thiophen-2-ylmethyl)ethan-1-amine
25I-NMePyr
25I-NMePyr; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(pyridin-2-ylmethyl)ethan-1-amine
25I-NBCN
25I-NBCN; N-(2-Cyanobenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NBAm
25I-NBAm; N-(2-Carbamoylbenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NMeInd
25I-NMeInd; N-(Indole-3-ylmethyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NNap2
25I-NNap2; 4-Iodo-2,5-dimethoxy-N-(naphthalen-1-ylmethyl)phenethylamine
25I-NBMeOH
25I-NBMeOH; N-[2-(Hydroxymethyl)benzyl]-4-iodo-2,5-dimethoxyphenethylamine
25I-NDHF
25I-NDHF; 4-Iodo-2,5-dimethoxy-N-(tetrahydrofuran-2-ylmethyl)phenethylamine
25I-N2Nap3OH
25I-N2Nap3OH; N-(3-Hydroxynaphthalen-2-yl)-4-iodo-2,5-dimethoxyphenethylamine
25I-N1Nap2OH
25I-N1Nap2OH; N-[(2-Hydroxynaphthalen-1-yl)methyl]-4-iodo-2,5-dimethoxyphenethylamine
25I-NBOH45MD
25I-NBOH45MD; N-(2-Hydroxy-4,5-methylenedioxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-N2Nap1OH
25I-N2Nap1OH; N-[(1-Hydroxynaphthalen-2-yl)methyl]-4-iodo-2,5-dimethoxyphenethylamine
25I-NB34MD
25I-NB34MD; 4-Iodo-2,5-dimethoxy-N-(3,4-methylenedioxybenzyl)phenethylamine
25I-NBpTFM
25I-NBpTFM; 4-Iodo-2,5-dimethoxy-N-[4-(trifluoromethyl)benzyl]phenethylamine
25I-NBTFM
25I-NBTFM; 4-Iodo-2,5-dimethoxy-N-[2-(trifluoromethyl)benzyl]phenethylamine
25I-NBF
25I-NBF; Cimbi-21
25I-NB4F · 25I-NBpF
25I-NB4F; N-(4-Fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
25I-NB
25I-NB; N-Benzyl-4-iodo-2,5-dimethoxyphenethylamine
N4MT3M-2C-I
N4MT3M-2C-I; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(4-methoxythiophen-3-yl)methyl]ethan-1-amine
N3MT2M-2C-I
N3MT2M-2C-I; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(3-methoxythiophen-2-yl)methyl]ethan-1-amine
25I-NEPOMe
25I-NEPOMe; N-[2-(4-Iodo-2,5-dimethoxyphenyl)ethyl]-1-(2-methoxyphenyl)ethan-1-amine
25I-NB3OMe
25I-NB3OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)ethan-1-amine
25I-NB4OMe
25I-NB4OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(4-methoxybenzyl)ethan-1-amine
25I-NB4B
25I-NB4B; N-(4-Bromobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
25I-NB3B
25I-NB3B; N-(3-Bromobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
25I-NBBr · 25I-NB2B
25I-NBBr; N-(2-Bromobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
DOI-NBOMe
DOI-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxyamphetamine
10477
N-[2-(2-Chlorophenyl)ethyl]acetamide
10568
3-[(4-Fluorophenyl)methyl]-N-methylpentan-3-amine
10566
1-(4-Fluorophenyl)-N,2-dimethylpropan-2-amine
10515
N-Ethyl-2-methyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine
10502
3-[(3-Fluorophenyl)methyl]-N-methylpentan-3-amine
10500
1-(3-Fluorophenyl)-N,2-dimethylpropan-2-amine
DMPEA-NBOMe · 25H-NBOMe
DMPEA-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxyphenethylamine
25B-NB2OMe · 25B-NBOMe
25B-NB2OMe; Cimbi-36
25D-NBOMe
25D-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxy-4-methylphenethylamine
25C-NB2OMe · 25C-NBOMe
25C-NB2OMe; Cimbi-82
25E-NBOMe
25E-NBOMe; 4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25T4-NBOMe
25T4-NBOMe; 4-Isopropylthio-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25EF-NBOMe
25EF-NBOMe; 4-(2-Fluoroethyl)-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25TFM-NBOMe
25TFM-NBOMe; Cimbi-138
25IP-NBOMe
25IP-NBOMe; 4-Isopropyl-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25CN-NBOMe
25CN-NBOMe; 2,5-Dimethoxy-4-{2-[(2-methoxybenzyl)amino]ethyl}benzonitrile
25F-NBOMe
25F-NBOMe; 2-(4-Fluoro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine
25N-NBOMe
25N-NBOMe; 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethan-1-amine
245-NBOMe
245-NBOMe; N-(2-Methoxybenzyl)-2-(2,4,5-trimethoxyphenyl)ethan-1-amine
25P-NBOMe
25P-NBOMe; 2-(2,5-Dimethoxy-4-propylphenyl)-N-(2-methoxybenzyl)ethan-1-amine
25T-NBOMe
25T-NBOMe; 2-[2,5-Dimethoxy-4-(methylsulfanyl)phenyl]-N-(2-methoxybenzyl)ethan-1-amine
25T2-NBOMe
25T2-NBOMe; 2-[4-(Ethylsulfanyl)-2,5-dimethoxyphenyl]-N-(2-methoxybenzyl)ethan-1-amine
25T7-NBOMe
25T7-NBOMe; 2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-(2-methoxybenzyl)ethan-1-amine
IBOX
IBOX; 8-Iodo-7-methoxy-2,3,4,5-tetrahydro-1-benzoxepin-4-amine
Propargylpemoline
Propargylpemoline
10846
2-(Dimethylamino)-5-methyl-5-phenyl-1,3-oxazol-4(5H)-one
738
2-(4-Iodo-2,5-dimethoxyphenyl)cyclopropanamine
25I-NBMeOH
25I-NBMeOH; N-[2-(Hydroxymethyl)benzyl]-4-iodo-2,5-dimethoxyphenethylamine
DOI-NBOH
DOI-NBOH; 2-({[1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-yl]amino}methyl)phenol
25I-NB3OMe
25I-NB3OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)ethan-1-amine
25I-NB4OMe
25I-NB4OMe; 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(4-methoxybenzyl)ethan-1-amine
26 September 2016 · Creative Commons BY-NC-SA ·